Novel "plum pudding" gels as potential drug-eluting stent coatings: Controlled release of fluvastatin

Journal of Biomedical Materials Research - Part A

Volumn 79, Issue 4, 2006, Pages 923-933

  McGillicuddy, F C ^a   Lynch, I ^a,b   Rochev, Y A ^c   Burke, M ^c   Dawson, K A ^a   Gallagher, W M ^a   Keenan, A K ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b LUND UNIVERSITY   (Sweden)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Fluvastatin; Local drug delivery; Microgels; NiPAAm NtBAAm; Stent wires

Indexed keywords

COATINGS; CONTROLLED DRUG DELIVERY; COPOLYMERS; DIFFUSION; HYDROPHILICITY; HYDROPHOBICITY;

FICKIAN DIFFUSION; FLUVASTATIN; IN-STENT RESTENOSIS (ISR); MICROGEL; MOTIFS; STENT WIRES; STOKES-EINSTEIN EQUATION;

GELS;

ACRYLAMIDE DERIVATIVE; COPOLYMER; FLUINDOSTATIN; N TERT BUTYLACRYLAMIDE; POLY(N ISOPROPYLACRYLAMIDE);

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORONARY ARTERY; DIFFUSION COEFFICIENT; DRUG ACTIVITY; DRUG ELUTING STENT; ELUTION; FILM; GEL; GUIDE WIRE; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; MALE; MATERIAL COATING; SMOOTH MUSCLE FIBER;

ANTICHOLESTEREMIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CORONARY VESSELS; DELAYED-ACTION PREPARATIONS; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDOLES; MATERIALS TESTING; MYOCYTES, SMOOTH MUSCLE; POLYMETHACRYLIC ACIDS; STENTS;

EID: 33845494732     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30839     Document Type: Article

References (32)

1. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361:247-249.
2. Domb AJ. Polymeric carriers for regional drug therapy. Mol Med Today 1995;1:134-139.
3. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-493.
4. Indolfi C, Cioppa A, Stabile E, Di Lorenzo E, Esposito G, Pisani A, Leccia A, Cavuto L, Stingone AM, Chieffo A, Capozzolo C, Chiariello M. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 2000;35:214-221.
5. Musial J, Undas A, Gajewski P, Jankowski M, Sydor W, Szczeklik A. Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol 2001;77:247-253.
6. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-1965.
7. Schror K. Platelet reactivity and arachidonic acid metabolism in type II hyperlipoproteinaemia and its modification by cholesterol-lowering agents. Eicosanoids 1990;3:67-73.
8. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-487.
9. Yeung AC, Tsao P. Statin therapy: Beyond cholesterol lowering and antiinflammatory effects. Circulation 2002;105:2937,2938.
10. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001;108:399-405.
11. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-3024.
12. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
13. Kavanagh CA, Gorelova TA, Selezneva II, Rochev YA, Dawson KA, Gallagher WM, Gorelov AV, Keenan AK. Poly(N-isopropylacrylamide) copolymer films as vehicles for the sustained delivery of proteins to vascular endothelial cells. J Biomed Mater Res A 2005;72:25-35.
14. Wilson SJ, Gorelov AV, Rochev YA, McGillicuddy F, Dawson KA, Gallagher WM, Keenan AK. Extended delivery of the antimitotic agent colchicine from thermoresponsive N-isopropylacrylamide-based copolymer films to human vascular smooth muscle cells. J Biomed Mater Res A 2003;67:667-673.
15. Doorty KB, Golubeva TA, Gorelov AV, Rochev YA, Allen LT, Dawson KA, Gallagher WM, Keenan AK. Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells. Cardiovasc Pathol 2003;12:105-110.
16. Lynch I, De Gregorio P, Dawson, KA. Simultaneous release of hydrophobic and cationic solutes from thin-film "plum-pudding" gels: A multifunctional platform for surface drug delivery? J Phys Chem B 2005;109:6257-6261.
17. Lynch I, Dawson K. Synthesis and characterization of an extremely versatile structural motif called the "plum-pudding" gel. J Phys Chem B 2003;107:9629-9637.
18. Li YD, Bae YC. Volume phase transition of submicron-sized NIPAM/BAm particles by photon correlation spectroscopy. J Appl Polym Sci 1998;67:2088-2092.
19. Yasuda HLC, Ikenberry LD. Permeability of solutes through hydrated polymer membranes. I. Diffusion of sodium chloride. Die Makromol Chem 1968;118:18-22.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
21. Hamelin BA, Turgeon J. Hydrophilicity/lipophilicity: Relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 1998;19:26-37.
22. Okano T, Bae HY, Kim SW. Thermally on-off switching polymers for drug permeation and release. J Controlled Release 1990;11:255-265.
23. Schild HG, Tirrel DA. Microcalorimetric detection of lower critical solution temperature in aqeous polymer solutions. J Phys Chem 1990;94:4352-4356.
24. Yoshida R, Sakai K, Ukano T, Sakurai Y, Bae YH, Kim SW. Surface-modulated skin layers of thermal responsive hydrogels as on-off switches. I. Drug release. J Biomater Sci Polym Ed 1991;3:155-162.
25. Zhang XZ, Jo Lewis P, Chu CC. Fabrication and characterization of a smart drug delivery system: Microsphere in hydrogel. Biomaterials 2005;26:3299-3309.
26. Lynch I, Dawson, KA. Release of model compounds from "plum- pudding"-type gels comprised of microgel particles randomly dispersed in a gel matrix. J Phys Chem B 2004;108:10893-10898.
27. Kopia GA, Llanos G, Falotico R, Papandreou G, Lauer M, Fischeil T, Devries J, Carter A, Tio F, Piotrovsky V, Dooley JF. Sirolimus-eluting stents: Antirestenosis efficacy versus local and systemic pharmacokinetics in a porcine coronary model. Am J Cardiol 2002;90 (Suppl. 6A):117H.
28. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology. Drug-eluting stents, Part I. Circulation 2003;107:2274-2279.
29. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Ballon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
30. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-1193.
31. Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Bohm M. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 2000;102:3104-3110.
32. Grobbee DE, Bots ML. Atherosclerotic disease regression with statins: Studies using vascular markers. Int J Cardiol 2004;96:447-459.